标题
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
作者
关键词
-
出版物
ONCOGENE
Volume 37, Issue 21, Pages 2850-2862
出版商
Springer Nature
发表日期
2018-03-05
DOI
10.1038/s41388-018-0135-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma
- (2016) Aldwin Suryo Rahmanto et al. EMBO JOURNAL
- Divergent clonal selection dominates medulloblastoma at recurrence
- (2016) A. Sorana Morrissy et al. NATURE
- Myc and cell cycle control
- (2015) Gabriel Bretones et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
- (2015) Rebecca M. Hill et al. CANCER CELL
- BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
- (2015) Anton George Henssen et al. Oncotarget
- Therapeutic Strategies to Inhibit MYC
- (2014) M. R. McKeown et al. Cold Spring Harbor Perspectives in Medicine
- NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
- (2014) Giulio Fiaschetti et al. Acta Neuropathologica Communications
- Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier
- (2013) C Albanese et al. BRITISH JOURNAL OF PHARMACOLOGY
- Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor
- (2013) T K Albert et al. BRITISH JOURNAL OF PHARMACOLOGY
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
- (2013) Z. Cheng et al. CLINICAL CANCER RESEARCH
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Stem Cells Expanded from the Human Embryonic Hindbrain Stably Retain Regional Specification and High Neurogenic Potency
- (2013) J. Tailor et al. JOURNAL OF NEUROSCIENCE
- Oncoprotein stabilization in brain tumors
- (2013) S-M Hede et al. ONCOGENE
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Role of MYC in Medulloblastoma
- (2013) M. F. Roussel et al. Cold Spring Harbor Perspectives in Medicine
- Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
- (2012) Fredrik J. Swartling et al. CANCER CELL
- Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
- (2012) A.L. Schmidt et al. CNS & Neurological Disorders-Drug Targets
- The bromodomain interaction module
- (2012) Panagis Filippakopoulos et al. FEBS LETTERS
- Subgroup-specific structural variation across 1,000 medulloblastoma genomes
- (2012) Paul A. Northcott et al. NATURE
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
- (2012) Cole Trapnell et al. Nature Protocols
- MYC Is Activated by USP2a-Mediated Modulation of MicroRNAs in Prostate Cancer
- (2012) Barbara Benassi et al. Cancer Discovery
- Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor
- (2012) Meihua Li et al. Cancer Genetics
- MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma
- (2011) Sarra L. Ryan et al. ACTA NEUROPATHOLOGICA
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies
- (2011) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Transcriptomes of the B and T Lineages Compared by Multiplatform Microarray Profiling
- (2011) M. W. Painter et al. JOURNAL OF IMMUNOLOGY
- Pleiotropic role for MYCN in medulloblastoma
- (2010) F. J. Swartling et al. GENES & DEVELOPMENT
- Subtypes of medulloblastoma have distinct developmental origins
- (2010) Paul Gibson et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and theMYCandMYCNLoci
- (2009) Stefan Pfister et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification ofN,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor
- (2009) Maria Gabriella Brasca et al. JOURNAL OF MEDICINAL CHEMISTRY
- The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound
- (2009) Simona Caporali et al. PHARMACOLOGICAL RESEARCH
- Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells
- (2009) J. J. Molenaar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
- (2009) P. Hydbring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More